LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 151 | |
4 mg | In stock | $ 256 | |
8 mg | In stock | $ 384 | |
20 mg | In stock | $ 904 | |
40 mg | In stock | $ 1446 |
Description | LY2874455 has been used in trials studying the treatment of Advanced Cancer. |
Targets&IC50 | FGFR4: 6 nM, FGFR3: 6.4 nM, FGFR1: 2.8 nM, FGFR2: 2.6 nM, VEGFR2: 7 nM |
In vitro | Cells (2,000 per well) are first grown in RPMI for 6 hours and treated with LY2874455 at 37 ℃ for 3 days. The cells are stained at 37℃ for 4 hours and then solubilized at 37℃ for 1 hour. Finally, the plate is read at 570 nm using a plate reader (Spectra Max Gemini XS). (Only for Reference) |
Synonyms | LY-2874455, LY 2874455 |
CAS No. | 1254473-64-7 |
Chemical Formula | C21H19Cl2N5O2 |
Molecular Weight | 444.32 |
Solubility | DMSO: 82 mg/mL (184.6 mM) Ethanol: 53 mg/mL (119.3 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom